#18 Aubrey de Grey | The Big 2025 Interview
LEVITY25 Helmi 2025

#18 Aubrey de Grey | The Big 2025 Interview

In this in-depth conversation, Dr. Aubrey de Grey discusses his Robust Mouse Rejuvenation (RMR) studies at the LEV Foundation and why he believes we're close to achieving the crucial RMR milestone within just three years - a breakthrough that could transform aging research forever.


You'll also hear about:

His predictions for reaching Longevity Escape Velocity by the late 2030s

What he would change about Bryan Johnson's longevity algorithm

How reaching RMR could trigger a global "war on aging"

Why AI won't solve aging without proper experimental data

How Demis Hassabis is the smartest person Aubrey's ever met

His involvement in designing the XPRIZE Healthspan competition

His rebuttal to Mark Hamalainen's "replacement strategy" approach

The divide-and-conquer approach to aging and why it's superior


🚀 Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/


-- CHAPTERS --

00:00 Introduction and Welcome

03:15 The Background to LEV Foundation and the Robust Mouse Rejuvenation Studies

12:05 The Robust Mouse Rejuvenation Studies

18:10 Latest Results from the Mouse Rejuvenation Experiments

25:42 Reaching RMR soon and LEV in 12-15 years

33:47 Healthspanners in public - lifespanners in private?

37:03 The Replacement Strategy Debate with Mark Hamalainen

45:40 The Very, Very Difficult Challenge of Gradually Replacing the Brain

54:46 Advanced bioengineering

57:34 The Debate with Peter Fedichev

01:11:57 Understanding Aging from an Evolutionary Perspective

01:17:05 Artificial Intelligence and Longevity Research

01:26:42 Is believing in AI hopium?

1:28:27 Aubrey’s Involvement in the XPRIZE Healthspan Competition

1:38:56 Special Economic Zones and Regulatory Challenges

1:47:27 What Aubrey would do with Bryan Johnson’s algorithm

1:50:49 What Excites Aubrey Most About the Future

1:51:57 Book Recommendations and Closing Thoughts

🗞️ SUBSCRIBE to the LEVITY newsletter: reachlevity.com/subscribe

Get all LEVITY DeSci content here: reachlevity.com/t/desci (sorry about the wrong link in the episode)


📕 Check out Patrick's book: https://mitpress.mit.edu/9780262543163/the-case-against-death/

📗 Check out Peter's book (only available in Swedish): https://www.adlibris.com/sv/bok/evigt-ung-min-och-manniskans-drom-om-ododligheten-9789179652524


-----


Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: reachlevity.com/subscribe


LEVITY is co-hosted by Patrick Linden, philosopher and author, and Peter Ottsjö, journalist and author.

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(39)

#37 The Anti-Catastrophe League

#37 The Anti-Catastrophe League

Tom Ough tells us about the Big Things that may end humanity - and what we can do and in some cases have done to prevent these. Did you know that if all the risks, the one that is most likely to end y...

16 Joulu 202544min

#36 How crypto is sparking a longevity frenzy

#36 How crypto is sparking a longevity frenzy

Today we’re diving into one of the strangest and most ambitious ideas in longevity: using crypto trading to fund real-time lifespan experiments.Benji Leibowitz, founder of pump.science, joins us to ex...

2 Joulu 20251h 48min

#35 The Anti-Aging Uprising: Felix Werth’s Political Attack on Death Itself

#35 The Anti-Aging Uprising: Felix Werth’s Political Attack on Death Itself

Valuable time is being lost because there is not enough funding for science with real life-extending potential. No major political party is promising to address aging, even though aging harms and kill...

11 Marras 20251h 24min

#34 Biomarkers of aging: How close are we, really? - A conversation with Sara Hägg

#34 Biomarkers of aging: How close are we, really? - A conversation with Sara Hägg

Sara Hägg, PhD is an associate professor at Karolinska Institutet, where she leads the Molecular Epidemiology of Aging Group. Her work focuses on human biomarkers of aging - especially biological age ...

28 Loka 20251h 36min

#33 “Can death be the answer?"  A conversation with philosopher Nicholas Agar

#33 “Can death be the answer?" A conversation with philosopher Nicholas Agar

We are always excited about the next technological solution. But what if it does not come? Or what if it comes only for the few, or with terrible side-effects? And while we are waiting for the easy te...

7 Loka 20251h 44min

#32 “Medical malpractice”: Matt Kaeberlein on biological age tests

#32 “Medical malpractice”: Matt Kaeberlein on biological age tests

One idea I’ve had lately is to put together a list of people to trust in geroscience and the longevity field more broadly. (And I might do it - keep an eye on reachlevity.com- and subscribe while you’...

23 Syys 20251h 50min

# 31 He wants to save your pet with cryo - The Kai Micah Mills interview

# 31 He wants to save your pet with cryo - The Kai Micah Mills interview

When you give a child a pet, you also expose them to death—since most pets pass away long before their owners. But what if we could cryopreserve Buddy or Tiger, and bring them back from suspended anim...

9 Syys 20252h 8min

#30 Soon you'll take a drug designed by AI  | Alex Zhavoronkov

#30 Soon you'll take a drug designed by AI | Alex Zhavoronkov

As you may have heard, AI-designed medicines have crossed a historic line. In this episode, Alex Zhavoronkov - CEO of Insilico Medicine and founder of ARDD walks us through how Insilico’s rentosertib ...

26 Elo 20252h 13min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
tiedekulma-podcast
utelias-mieli
rss-poliisin-mieli
rss-duodecim-lehti
radio-antro
rss-ylistys-elaimille
rss-sosiopodi
filocast-filosofian-perusteet
rss-lihavuudesta-podcast
docemilia
mielipaivakirja
rss-tervetta-skeptisyytta